Mc4r (original) (raw)
Latest News for: mc4r
Kalohexis Announces Publication in Nature Communications Highlighting Dual MC3R/MC4R Activation as a Novel, Durable Mechanism ...
Globe Gazette 30 May 2026
Dual Activation of MC3R and MC4R Drives Weight Loss and Reduces Food Intake in Male Primates with Obesity ... .
Kalohexis Announces Publication in Nature Communications Highlighting Dual MC3R/MC4R Activation as a Novel, Durable Mechanism that Drives Weight Loss
PR Newswire 29 May 2026
Dual Activation of MC3R and MC4R Drives Weight Loss and Reduces Food Intake in Male Primates with Obesity ... Kalohexis is currently developing a novel oral dual MC3R/MC4R agonist, 710GO, which ...
Congruence Announces First Dosing in Phase 1/1b Clinical Trial of CGX-926, a First-in-Class Oral MC4R Corrector for Genetic Obesity
PR Newswire 19 Mar 2026
The first-in-human Phase 1/1b study is designed to evaluate the safety, tolerability, and pharmacokinetics of CGX-926, while also exploring preliminary efficacy in individuals with MC4R-deficient obesity.
- 1
Article Search
tools
You can search using any combination of the items listed below.
Language:
Sort:
Indexed:
Search:
Duplicates: